Envoy Medical
COCH
17 hedge funds and large institutions have $4.59M invested in Envoy Medical in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
89% more funds holding
Funds holding: 9 → 17 (+8)
52% more capital invested
Capital invested by funds: $3.01M → $4.59M (+$1.58M)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
2.42% less ownership
Funds ownership: 8.42% → 6% (-2.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$481K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$288K |
| 3 |
State Street
Boston,
Massachusetts
|
+$103K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$95.6K |
| 5 |
Morgan Stanley
New York
|
+$84.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMC
Atlas Merchant Capital
New York
|
-$880K |
| 2 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$771K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$197K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$146K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.1K |
COCH Hedge Fund Activity: Q1 2024 in Review
17 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q1 2024, worth a combined $4.59M — up 52% from $3.01M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new COCH positions and 3 closed out — a net gain of 8 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was HighTower Advisors, opening a new position worth an estimated $481K. The largest seller was Atlas Merchant Capital, cutting an estimated $880K.
- 17 institutional investors held Envoy Medical (COCH) as of Q1 2024, up from 9 in Q4 2023.
- Funds reported $4.59M of Envoy Medical stock for Q1 2024, up 52% quarter-over-quarter.
- 11 funds opened new Envoy Medical positions in Q1 2024 and 3 closed out, a net change of +8 holders.
- The largest Envoy Medical buyer in Q1 2024 was HighTower Advisors, an estimated $481K added.
- The largest Envoy Medical seller in Q1 2024 was Atlas Merchant Capital, an estimated $880K sold.
Based on aggregated 13F filings for Q1 2024.